FDA-authorized Paxlovid by Pfizer offers no benefit to non-seniors
A study of over 100 thousand patients published in the New England Journal of Medicine on August 24, 2022, shows
Read MoreA study of over 100 thousand patients published in the New England Journal of Medicine on August 24, 2022, shows
Read MoreSILVER SPRINGS, MD, December 22, 2021 – Today, the Food and Drug Administration authorized Pfizer’s Paxlovid for adults and children
Read More